Dr. Nathan Steinle: Pegcetacoplan's Long-Term Efficacy in the GALE Extension Study.

Published Date: 06 Aug 2023

Pegcetacoplan injection, which was presented at ASRS 2023, demonstrated increasing treatment effects for patients with geographic atrophy over the course of 30 months, with a safety profile that was consistent with earlier phase 3 data.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How access to specialized cancer centers affects glioblastoma outcomes

2.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

3.

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

4.

U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain

5.

Beyond What Is Visible in Myelofibrosis?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot